As the global population ages, healthcare professionals increasingly focus on healthy aging and understanding conditions like frailty in older adults [1], [8]. Frailty represents a state of reduced physiological reserve, leaving individuals more vulnerable to stressors, functional decline, and adverse health outcomes [1], [2]. Managing chronic diseases in this population requires a careful balance between aggressive treatment targets and the prevention of treatment burdens, such as hypoglycemia, falls, and medication side effects [1].
The Intersection of Frailty and Chronic Diseases
Older adults frequently manage multiple chronic conditions, including type 2 diabetes, hypertension, and atrial fibrillation [1], [3], [5]. However, the presence of frailty and advanced age changes how these conditions should be managed. For instance, older adults with type 2 diabetes are often subjected to intensive glucose-lowering therapies that carry a high likelihood of hypoglycemia and functional decline [1]. Similarly, conditions like atrial fibrillation pose complex management challenges in frail patients due to a heightened vulnerability to both stroke and major bleeding events [2]. Research indicates that frail individuals may face a significantly higher mortality risk and greater incidence of stroke compared to their non-frail peers [2].
Tailoring Medication and Deprescribing Strategies
Standard treatment guidelines are typically designed for younger, more robust populations, creating a clinical evidence gap for adults aged 75 and older [4]. International recommendations advocate for individualized glycemic targets, yet clinicians often need guidance on when and how to de-intensify therapies as a patient's health status changes [1]. Frailty-informed deprescribing frameworks help reduce treatment burdens by scaling back medications that may cause more harm than benefit in later life [1]. In cardiovascular care, evaluating the risks and benefits of lipid-lowering or blood pressure therapies requires careful consideration of a patient's overall biological age, life expectancy, and personal values rather than chronological age alone [3], [4].
Assessing Frailty and Stroke Risk Over Time
Frailty is not a static state; it is dynamic and can change over time [6]. Longitudinal studies examining frailty trajectories demonstrate that worsening frailty status is closely associated with an increased risk of incident stroke and other adverse events [6]. Validated screening tools, such as deficit-accumulation frailty indexes, the Clinical Frailty Scale, and the Edmonton Frailty Scale, help clinicians identify vulnerability levels and tailor care pathways accordingly [2], [5], [8]. Recognizing conditions linked to muscle loss and functional decline, such as sarcopenia in older adults with diabetes, is also essential for a comprehensive geriatric assessment [8].
Acute Care and Post-Hospitalization Vulnerability
Acutely hospitalized older persons frequently present with acute functional decline, defined as a sudden reduction in the ability to perform activities of daily living in the days leading up to admission [7]. Studies show that older patients presenting with acute functional decline often carry multiple systemic diagnoses and daily medications [7]. Comprehensive geriatric assessments in acute and post-discharge settings are vital for identifying severe frailty, predicting outcomes like nursing home admission or mortality, and ensuring continuity of care [5], [7].
Sources
- 1. Frailty-Informed Deprescribing of Glucose-Lowering Therapy in Older Adults with Type 2 Diabetes: A Pragmatic Clinical Framework
- 2. Frailty and advanced age in atrial fibrillation: Implications for treatment strategies and clinical outcomes - A systematic review
- 3. Hypertension treatment strategies for older adults
- 4. Lipid-lowering therapy for primary prevention of cardiovascular disease in adults aged 75 years and older: a narrative review
- 5. Primary and Secondary Prevention of Ischemic Stroke in Elderly Patients with Cardiovascular Disease: The Role of Frailty and Care Pathways
- 6. Frailty Trajectories and Incident Stroke Risk in People Aged 50 Years and Older: A Three-Cohort Prospective Analysis
- 7. Impact of Acute Functional Decline on Frailty and Mortality in Acutely Hospitalized Older Persons
- 8. Frailty and Sarcopenia in Elderly Diabetes Mellitus